References
Fitzpatrick AP, Travill CM, Vardas PE, et al. Recurrent symptoms after ventricular pacing in unexplained syncope. Pacing Clin Electrophysiol 1990;13:619–624.
Kenny RA, Ingram A, Bayliss J, Sutton R. Head-up tilt: A useful test for the investigation of unexplained syncope. Lancet 1986;2:1352–1355.
Fitzpatrick AP, Theodorakis G, Ahmed R, et al. Dual chamber pacing aborts vasovagal syncope induced by head-up 6° tilt. Pacing Clin Electrophysiol 1991;14:13–19.
Samoil D, Grubb BP, Brewster P, et al. Comparison of single and dual chamber pacing techniques in prevention of upright tilt-induced vasovagal syncope. Eur J Cardiac Pacing Electrophysiol 1993;3:36–41.
Sra JS, Jazayeri MR, Avitail B, et al. Comparison of cardiac pacing with drug therapy and the treatment of neurocardiogenic (vasovagal) syncope with bradycardia or asystole. New Engl J Med 1993;328:1085–1090.
Petersen MEV, Chamberlain-Webber R, Fitzpatrick AP, et al. Permanent pacing for cardioinhibitory malignant vasovagal syndrome. Br Heart J 1994;71:274–281.
Sutton R, Petersen MEV, Brignole M, et al. Proposed classification for tilt-induced vasovagal syncope. Eur J Cardiac Pacing Electrophysiol 1992;2:108–183.
Sutton R for the vasovagal international study (VASIS). Is dual chamber pacing efficacious in treatment of neurally mediated tilt positive cardioinhibitory syncope? Pacemaker vs. no therapy: A multi-centre randomized study. Eur J Cardiac Pacing Electrophysiol 1993;3:169–172.
Sheldon RS, Gent M, Roberts RS, et al. North American vasovagal pacemaker study: Study design and organization. Pacing Clin Electrophysiol 1997;20:827–828.
Sutton R, Petersen MEV. First steps towards a pacing algorithm for vasovagal syncope. Pacing Clin Electrophysiol 1997;20:829–831.
Benditt D, Sutton R, Gammage MD, et al. Clinical experience with Thera DR rate-drop response pacing algorithm in carotid sinus syndrome and vasovagal syncope. Pacing Clin Electrophysiol 1997;20:183–189.
Connolly SJ, Sheldon R, Roberts RS, Gent M. The North American vasovagal pacemaker study (VPS). A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope. J Am Coll Cardiol 1999;33:16–20.
Sutton R. Pacing for amelioration of vasovagal syncope. Eur J Cardiac Pacing Electrophysiol 1997;7:44–45.
Sheldon R, Rose S. Components of clinical trials for vasovagal syncope. Europace 2001;3:233–240.
Sutton R, Brignole M, Menozzi C, et al. Dual chamber pacing in the treatment of neurally mediated tilt-positive cardioinhibitory syncope. Pacemaker versus no therapy: A multi-centre randomized study. Circulation 2000;102:294–299.
Ammirati F, Colivicchi F, Toscano S, et al. DDDpacing with rate-drop response function versus DDI with rate hysteresis pacing for cardioinhibitory vasovagal syncope. Pacing Clin Electrophysiol 1998;21:2178–2181.
Kurbaan AS, Franzen AC, Stack Z, Heaven D, Mathur G, Sutton R. Determining the optimal pacing intervention rate for vasovagal syncope. J Intervent Card Electrophysiol 2000;4:483–589.
Ammirati F, Colivicchi F, Santini M. Permanent cardiac pacing versus medical treatment for the prevention of recurrent vasovagal syncope. A multi-centre, randomized, controlled trial. Circulation 2001;104:52–57.
Fitzpatrick AP, Ahmed R, Williams S, Sutton R. A randomized trial of medical therapy in 'malignant vasovagal syndrome' or 'neurally mediated bradycardia hypotension syndrome.' Eur J Cardiac Pacing Electrophysiol 1991;1:99–102.
Mahanonda N, Bhuripanjo K, Kangkagate C, et al. Randomized, double-blind, placebo-controlled trial of oral Atenolol in patients with unexplained syncope and positive upright tilt table test results. Am Heart J 1995;130:1250–1253.
Madrid AH, Ortega J, Rebollo JG, et al. Lack of efficacy of Atenolol for the prevention of neurally mediated syncope in a highly symptomatic population: A prospectus, doubleblind, randomized and placebo-controlled study. J Am Coll Cardiol 2001;37:554–559.
Connolly SJ, Sheldon R, Thorpe KE, et al. for VPS 2 investigators. Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope. Second vasovagal pacemaker study (VPS-2): A randomized trial. JAMA 2003;209:2224–2229.
Raviele A, Giada F, Sutton R, et al. The vasovagal syncope and pacing (SYNPACE) trial: Rationale and study design. Europace 2001;3:336–341.
Giada F, Raviele A, Menozzi C, Speca G, Grazi S, Gasparini G, Sutton R. The vasovagal syncope and pacing trial (SYNPACE): A randomized placebo controlled study of permanent cardiac pacing for treatment of recurrent vasovagal syncope (Abstract). Pacing Clin Electrophysiol 2003;26:1016.
Ammirati F, Colivicchi F, Altamura V, et al. Permanent cardiac pacing for recurrent vasovagal syncope refractory to pharmacological treatment: Long-term effect of different pacing modalities (Abstract). Pacing Clin Electrophysiol 2002;24:599.
Kurbaan AS, Freanzen A-C, Heaven D, et al. Cardioinhibition during tilt testing identifies patients who may benefit from pacing. Pacing Clin Electrophysiol 2000;23:1792–1794.
Kurbaan AS, Erickson M, Petersen ME, et al. Respiratory changes in vasovagal syncope. J Cardiovasc Electrophysiol 2000;11:607–611.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sutton, R. Has Cardiac Pacing a Role in Vasovagal Syncope?. J Interv Card Electrophysiol 9, 145–149 (2003). https://doi.org/10.1023/A:1026272004709
Issue Date:
DOI: https://doi.org/10.1023/A:1026272004709